These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 29125
21. Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Schoffelmeer AN, Rice KC, Jacobson AE, Van Gelderen JG, Hogenboom F, Heijna MH, Mulder AH. Eur J Pharmacol; 1988 Sep 13; 154(2):169-78. PubMed ID: 2906610 [Abstract] [Full Text] [Related]
22. C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor. Nichols DE, Jacob JN, Hoffman AJ, Kohli JD, Glock D. J Med Chem; 1984 Dec 13; 27(12):1701-5. PubMed ID: 6502600 [Abstract] [Full Text] [Related]
25. The significance of COMT activity in controlling dopamine agonist levels in brain and serum: studies with a prodrug and a metabolite of 6,7-ADTN. Rollema H, Westerink BH, Mulder TB, Dijkstra D, Feenstra MG, Horn AS. Eur J Pharmacol; 1980 Jun 27; 64(4):313-23. PubMed ID: 7389825 [Abstract] [Full Text] [Related]
29. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99. Martin GE, Haubrich DR, Williams M. Eur J Pharmacol; 1981 Nov 19; 76(1):15-23. PubMed ID: 7318920 [Abstract] [Full Text] [Related]
30. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. Johansson AM, Arvidsson LE, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Clark D, Carlsson A, Sanchez D, Andersson B. J Med Chem; 1985 Aug 19; 28(8):1049-53. PubMed ID: 3927002 [Abstract] [Full Text] [Related]
31. 2-substituted tetralin derivatives as conformationally restricted butyrophenone analogs. Chan CC, Farmer PS, McKenzie G, Robertson H. Pharmazie; 1987 Jun 19; 42(6):369-71. PubMed ID: 2890175 [Abstract] [Full Text] [Related]
34. A stereochemical and conformational model of dopaminergic agonist and antagonist activity: further evaluation. Froimowitz M, Baldessarini RJ. J Pharm Sci; 1987 Jul 19; 76(7):557-64. PubMed ID: 3668819 [Abstract] [Full Text] [Related]
37. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively. Urwyler S, Markstein R. J Neurochem; 1986 Apr 19; 46(4):1058-67. PubMed ID: 2936868 [Abstract] [Full Text] [Related]
38. Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses. Friedman DJ, Budai D, Krause DN, Duckles SP. J Pharmacol Exp Ther; 1989 Sep 19; 250(3):853-9. PubMed ID: 2674420 [Abstract] [Full Text] [Related]
39. Sensitivity of compacta neurones in the rat substantia nigra slice to dopamine agonists. Pinnock RD. Eur J Pharmacol; 1983 Dec 23; 96(3-4):269-76. PubMed ID: 6676108 [Abstract] [Full Text] [Related]
40. Synthesis and in vivo distribution in rat brain of 11C-labelled N-alkylated ADTN derivatives. van der Werf JF, Vaalburg W, Korf J, Kuilman T, Wiegman T. Int J Appl Radiat Isot; 1984 May 23; 35(5):377-81. PubMed ID: 6610647 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]